Hexbyte  Tech News  Wired The Case for Expensive Antibiotics

Hexbyte Tech News Wired The Case for Expensive Antibiotics

|

Douglas Sacha/Getty ImagesDouglas Sacha/Getty ImagesA handful of years ago, a small pharmaceutical company quietly acquired the rights to an old but commonly used antibiotic. Few noticed until last week, when the new owner did something that’s recently become common in the world of pharmaceuticals: It abruptly raised the price. A lot.The manufacturer is called Nostrum…

Hexbyte  Hacker News  Computers IPOs are too expensive and cumbersome

Hexbyte Hacker News Computers IPOs are too expensive and cumbersome

|

Choose the subscription that is right for you Not sure which package to choose? Try full access for 4 weeks For 4 weeks receive unlimited Premium digital access to the FT’s trusted, award-winning business news Read more Be informed with the essentialnews and opinion MyFT – track the topics most important to you FT Weekend…